Although Hsp27 levels have been correlated with cancer patients’ clinicopathological and prognostic features, with higher expression associated with more advanced disease stage and poorer prognosis, until today, Hsp27 has not officially been established as a cancer biomarker in everyday clinical practice [2,29,30,31,32,33,34]. This evidence concerns the gene HSPB1 and cancer.